» Articles » PMID: 10037795

Activation of G12/G13 Results in Shape Change and Rho/Rho-kinase-mediated Myosin Light Chain Phosphorylation in Mouse Platelets

Overview
Journal J Cell Biol
Specialty Cell Biology
Date 1999 Feb 26
PMID 10037795
Citations 81
Authors
Affiliations
Soon will be listed here.
Abstract

Platelets respond to various stimuli with rapid changes in shape followed by aggregation and secretion of their granule contents. Platelets lacking the alpha-subunit of the heterotrimeric G protein Gq do not aggregate and degranulate but still undergo shape change after activation through thromboxane-A2 (TXA2) or thrombin receptors. In contrast to thrombin, the TXA2 mimetic U46619 led to the selective activation of G12 and G13 in Galphaq-deficient platelets indicating that these G proteins mediate TXA2 receptor-induced shape change. TXA2 receptor-mediated activation of G12/G13 resulted in tyrosine phosphorylation of pp72(syk) and stimulation of pp60(c-src) as well as in phosphorylation of myosin light chain (MLC) in Galphaq-deficient platelets. Both MLC phosphorylation and shape change induced through G12/G13 in the absence of Galphaq were inhibited by the C3 exoenzyme from Clostridium botulinum, by the Rho-kinase inhibitor Y-27632 and by cAMP-analogue Sp-5,6-DCl-cBIMPS. These data indicate that G12/G13 couple receptors to tyrosine kinases as well as to the Rho/Rho-kinase-mediated regulation of MLC phosphorylation. We provide evidence that G12/G13-mediated Rho/Rho-kinase-dependent regulation of MLC phosphorylation participates in receptor-induced platelet shape change.

Citing Articles

Structural basis of tethered agonism and G protein coupling of protease-activated receptors.

Guo J, Zhou Y, Yang Y, Guo S, You E, Xie X Cell Res. 2024; 34(10):725-734.

PMID: 38997424 PMC: 11443083. DOI: 10.1038/s41422-024-00997-2.


Platelet factor XIII-A regulates platelet function and promotes clot retraction and stability.

Mitchell J, Little G, Bye A, Gaspar R, Unsworth A, Kriek N Res Pract Thromb Haemost. 2023; 7(5):100200.

PMID: 37601014 PMC: 10439398. DOI: 10.1016/j.rpth.2023.100200.


Genomic Variation Affecting MPV and PLT Count in Association with Development of Ischemic Stroke and Its Subtypes.

Ludhiadch A, Sulena , Singh S, Chakraborty S, Sharma D, Kulharia M Mol Neurobiol. 2023; 60(11):6424-6440.

PMID: 37453995 DOI: 10.1007/s12035-023-03460-2.


Structure-Activity Relationship Analysis of Rhosin, a RhoA GTPase Inhibitor, Reveals a New Class of Antiplatelet Agents.

Dandamudi A, Seibel W, Tourdot B, Cancelas J, Akbar H, Zheng Y Int J Mol Sci. 2023; 24(4).

PMID: 36835579 PMC: 9961652. DOI: 10.3390/ijms24044167.


Rho GTPase Signaling in Platelet Regulation and Implication for Antiplatelet Therapies.

Dandamudi A, Akbar H, Cancelas J, Zheng Y Int J Mol Sci. 2023; 24(3).

PMID: 36768837 PMC: 9917354. DOI: 10.3390/ijms24032519.


References
1.
Aktories K, Jakobs K . Ni-mediated inhibition of human platelet adenylate cyclase by thrombin. Eur J Biochem. 1984; 145(2):333-8. DOI: 10.1111/j.1432-1033.1984.tb08558.x. View

2.
Nakai K, Suzuki Y, Kihira H, Wada H, Fujioka M, Ito M . Regulation of myosin phosphatase through phosphorylation of the myosin-binding subunit in platelet activation. Blood. 1997; 90(10):3936-42. View

3.
Ferrell Jr J, Martin G . Platelet tyrosine-specific protein phosphorylation is regulated by thrombin. Mol Cell Biol. 1988; 8(9):3603-10. PMC: 365415. DOI: 10.1128/mcb.8.9.3603-3610.1988. View

4.
Essler M, Amano M, Kruse H, Kaibuchi K, Weber P, Aepfelbacher M . Thrombin inactivates myosin light chain phosphatase via Rho and its target Rho kinase in human endothelial cells. J Biol Chem. 1998; 273(34):21867-74. DOI: 10.1074/jbc.273.34.21867. View

5.
GILMAN A, Murad F . Assay of cyclic nucleotides by receptor protein binding displacement. Methods Enzymol. 1974; 38:49-61. DOI: 10.1016/0076-6879(74)38010-x. View